Request for Covid-19 Impact Assessment of this Report
The United States Transforming Growth Factor Beta 1 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transforming Growth Factor Beta 1 market, reaching US$ million by the year 2028. As for the Europe Transforming Growth Factor Beta 1 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Transforming Growth Factor Beta 1 players cover Roche, Shionogi Ltd, Acceleron Pharma Inc, and Genzyme Corp, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Transforming Growth Factor Beta 1 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Pirfenidone
Galunisertib
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
IPF
Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transforming Growth Factor Beta 1 Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Transforming Growth Factor Beta 1 by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Transforming Growth Factor Beta 1 by Country/Region, 2017, 2022 & 2028
2.2 Transforming Growth Factor Beta 1 Segment by Type
2.2.1 Pirfenidone
2.2.2 Galunisertib
2.2.3 Others
2.3 Transforming Growth Factor Beta 1 Sales by Type
2.3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)
2.3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2017-2022)
2.3.3 Global Transforming Growth Factor Beta 1 Sale Price by Type (2017-2022)
2.4 Transforming Growth Factor Beta 1 Segment by Application
2.4.1 IPF
2.4.2 Cancer
2.4.3 Others
2.5 Transforming Growth Factor Beta 1 Sales by Application
2.5.1 Global Transforming Growth Factor Beta 1 Sale Market Share by Application (2017-2022)
2.5.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Application (2017-2022)
2.5.3 Global Transforming Growth Factor Beta 1 Sale Price by Application (2017-2022)
3 Global Transforming Growth Factor Beta 1 by Company
3.1 Global Transforming Growth Factor Beta 1 Breakdown Data by Company
3.1.1 Global Transforming Growth Factor Beta 1 Annual Sales by Company (2020-2022)
3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2020-2022)
3.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Company (2020-2022)
3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Company (2020-2022)
3.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2020-2022)
3.3 Global Transforming Growth Factor Beta 1 Sale Price by Company
3.4 Key Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transforming Growth Factor Beta 1 Product Location Distribution
3.4.2 Players Transforming Growth Factor Beta 1 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Transforming Growth Factor Beta 1 by Geographic Region
4.1 World Historic Transforming Growth Factor Beta 1 Market Size by Geographic Region (2017-2022)
4.1.1 Global Transforming Growth Factor Beta 1 Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Geographic Region
4.2 World Historic Transforming Growth Factor Beta 1 Market Size by Country/Region (2017-2022)
4.2.1 Global Transforming Growth Factor Beta 1 Annual Sales by Country/Region (2017-2022)
4.2.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Country/Region
4.3 Americas Transforming Growth Factor Beta 1 Sales Growth
4.4 APAC Transforming Growth Factor Beta 1 Sales Growth
4.5 Europe Transforming Growth Factor Beta 1 Sales Growth
4.6 Middle East & Africa Transforming Growth Factor Beta 1 Sales Growth
5 Americas
5.1 Americas Transforming Growth Factor Beta 1 Sales by Country
5.1.1 Americas Transforming Growth Factor Beta 1 Sales by Country (2017-2022)
5.1.2 Americas Transforming Growth Factor Beta 1 Revenue by Country (2017-2022)
5.2 Americas Transforming Growth Factor Beta 1 Sales by Type
5.3 Americas Transforming Growth Factor Beta 1 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transforming Growth Factor Beta 1 Sales by Region
6.1.1 APAC Transforming Growth Factor Beta 1 Sales by Region (2017-2022)
6.1.2 APAC Transforming Growth Factor Beta 1 Revenue by Region (2017-2022)
6.2 APAC Transforming Growth Factor Beta 1 Sales by Type
6.3 APAC Transforming Growth Factor Beta 1 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Transforming Growth Factor Beta 1 by Country
7.1.1 Europe Transforming Growth Factor Beta 1 Sales by Country (2017-2022)
7.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Country (2017-2022)
7.2 Europe Transforming Growth Factor Beta 1 Sales by Type
7.3 Europe Transforming Growth Factor Beta 1 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transforming Growth Factor Beta 1 by Country
8.1.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2017-2022)
8.1.2 Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2017-2022)
8.2 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type
8.3 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transforming Growth Factor Beta 1
10.3 Manufacturing Process Analysis of Transforming Growth Factor Beta 1
10.4 Industry Chain Structure of Transforming Growth Factor Beta 1
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transforming Growth Factor Beta 1 Distributors
11.3 Transforming Growth Factor Beta 1 Customer
12 World Forecast Review for Transforming Growth Factor Beta 1 by Geographic Region
12.1 Global Transforming Growth Factor Beta 1 Market Size Forecast by Region
12.1.1 Global Transforming Growth Factor Beta 1 Forecast by Region (2023-2028)
12.1.2 Global Transforming Growth Factor Beta 1 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transforming Growth Factor Beta 1 Forecast by Type
12.7 Global Transforming Growth Factor Beta 1 Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Transforming Growth Factor Beta 1 Product Offered
13.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Shionogi Ltd
13.2.1 Shionogi Ltd Company Information
13.2.2 Shionogi Ltd Transforming Growth Factor Beta 1 Product Offered
13.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Shionogi Ltd Main Business Overview
13.2.5 Shionogi Ltd Latest Developments
13.3 Acceleron Pharma Inc
13.3.1 Acceleron Pharma Inc Company Information
13.3.2 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Offered
13.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Acceleron Pharma Inc Main Business Overview
13.3.5 Acceleron Pharma Inc Latest Developments
13.4 Genzyme Corp
13.4.1 Genzyme Corp Company Information
13.4.2 Genzyme Corp Transforming Growth Factor Beta 1 Product Offered
13.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Genzyme Corp Main Business Overview
13.4.5 Genzyme Corp Latest Developments
13.5 Isarna Therapeutics GmbH
13.5.1 Isarna Therapeutics GmbH Company Information
13.5.2 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Offered
13.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Isarna Therapeutics GmbH Main Business Overview
13.5.5 Isarna Therapeutics GmbH Latest Developments
13.6 Scholar Rock
13.6.1 Scholar Rock Company Information
13.6.2 Scholar Rock Transforming Growth Factor Beta 1 Product Offered
13.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Scholar Rock Main Business Overview
13.6.5 Scholar Rock Latest Developments
13.7 Sirnaomics Inc
13.7.1 Sirnaomics Inc Company Information
13.7.2 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Offered
13.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sirnaomics Inc Main Business Overview
13.7.5 Sirnaomics Inc Latest Developments
13.8 Eli Lilly and Co
13.8.1 Eli Lilly and Co Company Information
13.8.2 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Offered
13.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Eli Lilly and Co Main Business Overview
13.8.5 Eli Lilly and Co Latest Developments
13.9 Formation Biologics Inc
13.9.1 Formation Biologics Inc Company Information
13.9.2 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Offered
13.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Formation Biologics Inc Main Business Overview
13.9.5 Formation Biologics Inc Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Transforming Growth Factor Beta 1 Product Offered
13.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
14 Research Findings and Conclusion
Table 1. Transforming Growth Factor Beta 1 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Transforming Growth Factor Beta 1 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Pirfenidone
Table 4. Major Players of Galunisertib
Table 5. Major Players of Others
Table 6. Global Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)
Table 7. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)
Table 8. Global Transforming Growth Factor Beta 1 Revenue by Type (2017-2022) & ($ million)
Table 9. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2017-2022)
Table 10. Global Transforming Growth Factor Beta 1 Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)
Table 12. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)
Table 13. Global Transforming Growth Factor Beta 1 Revenue by Application (2017-2022)
Table 14. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2017-2022)
Table 15. Global Transforming Growth Factor Beta 1 Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Transforming Growth Factor Beta 1 Sales by Company (2020-2022) & (K Units)
Table 17. Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2020-2022)
Table 18. Global Transforming Growth Factor Beta 1 Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2020-2022)
Table 20. Global Transforming Growth Factor Beta 1 Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution and Sales Area
Table 22. Players Transforming Growth Factor Beta 1 Products Offered
Table 23. Transforming Growth Factor Beta 1 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Transforming Growth Factor Beta 1 Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Transforming Growth Factor Beta 1 Sales Market Share Geographic Region (2017-2022)
Table 28. Global Transforming Growth Factor Beta 1 Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Transforming Growth Factor Beta 1 Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Transforming Growth Factor Beta 1 Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Transforming Growth Factor Beta 1 Sales Market Share by Country/Region (2017-2022)
Table 32. Global Transforming Growth Factor Beta 1 Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Transforming Growth Factor Beta 1 Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Transforming Growth Factor Beta 1 Sales by Country (2017-2022) & (K Units)
Table 35. Americas Transforming Growth Factor Beta 1 Sales Market Share by Country (2017-2022)
Table 36. Americas Transforming Growth Factor Beta 1 Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Transforming Growth Factor Beta 1 Revenue Market Share by Country (2017-2022)
Table 38. Americas Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)
Table 39. Americas Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)
Table 40. Americas Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)
Table 41. Americas Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)
Table 42. APAC Transforming Growth Factor Beta 1 Sales by Region (2017-2022) & (K Units)
Table 43. APAC Transforming Growth Factor Beta 1 Sales Market Share by Region (2017-2022)
Table 44. APAC Transforming Growth Factor Beta 1 Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Transforming Growth Factor Beta 1 Revenue Market Share by Region (2017-2022)
Table 46. APAC Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)
Table 47. APAC Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)
Table 48. APAC Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)
Table 49. APAC Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)
Table 50. Europe Transforming Growth Factor Beta 1 Sales by Country (2017-2022) & (K Units)
Table 51. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2017-2022)
Table 52. Europe Transforming Growth Factor Beta 1 Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2017-2022)
Table 54. Europe Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)
Table 55. Europe Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)
Table 56. Europe Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)
Table 57. Europe Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Transforming Growth Factor Beta 1
Table 67. Key Market Challenges & Risks of Transforming Growth Factor Beta 1
Table 68. Key Industry Trends of Transforming Growth Factor Beta 1
Table 69. Transforming Growth Factor Beta 1 Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Transforming Growth Factor Beta 1 Distributors List
Table 72. Transforming Growth Factor Beta 1 Customer List
Table 73. Global Transforming Growth Factor Beta 1 Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Transforming Growth Factor Beta 1 Sales Market Forecast by Region
Table 75. Global Transforming Growth Factor Beta 1 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Transforming Growth Factor Beta 1 Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Transforming Growth Factor Beta 1 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Transforming Growth Factor Beta 1 Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Transforming Growth Factor Beta 1 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Transforming Growth Factor Beta 1 Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Transforming Growth Factor Beta 1 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Transforming Growth Factor Beta 1 Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Transforming Growth Factor Beta 1 Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Transforming Growth Factor Beta 1 Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Transforming Growth Factor Beta 1 Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Application (2023-2028)
Table 93. Roche Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 94. Roche Transforming Growth Factor Beta 1 Product Offered
Table 95. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Roche Main Business
Table 97. Roche Latest Developments
Table 98. Shionogi Ltd Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 99. Shionogi Ltd Transforming Growth Factor Beta 1 Product Offered
Table 100. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Shionogi Ltd Main Business
Table 102. Shionogi Ltd Latest Developments
Table 103. Acceleron Pharma Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 104. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Offered
Table 105. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Acceleron Pharma Inc Main Business
Table 107. Acceleron Pharma Inc Latest Developments
Table 108. Genzyme Corp Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 109. Genzyme Corp Transforming Growth Factor Beta 1 Product Offered
Table 110. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Genzyme Corp Main Business
Table 112. Genzyme Corp Latest Developments
Table 113. Isarna Therapeutics GmbH Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 114. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Offered
Table 115. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Isarna Therapeutics GmbH Main Business
Table 117. Isarna Therapeutics GmbH Latest Developments
Table 118. Scholar Rock Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 119. Scholar Rock Transforming Growth Factor Beta 1 Product Offered
Table 120. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Scholar Rock Main Business
Table 122. Scholar Rock Latest Developments
Table 123. Sirnaomics Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 124. Sirnaomics Inc Transforming Growth Factor Beta 1 Product Offered
Table 125. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Sirnaomics Inc Main Business
Table 127. Sirnaomics Inc Latest Developments
Table 128. Eli Lilly and Co Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 129. Eli Lilly and Co Transforming Growth Factor Beta 1 Product Offered
Table 130. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Eli Lilly and Co Main Business
Table 132. Eli Lilly and Co Latest Developments
Table 133. Formation Biologics Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 134. Formation Biologics Inc Transforming Growth Factor Beta 1 Product Offered
Table 135. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 136. Formation Biologics Inc Main Business
Table 137. Formation Biologics Inc Latest Developments
Table 138. Novartis AG Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 139. Novartis AG Transforming Growth Factor Beta 1 Product Offered
Table 140. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 141. Novartis AG Main Business
Table 142. Novartis AG Latest Developments
List of Figures
Figure 1. Picture of Transforming Growth Factor Beta 1
Figure 2. Transforming Growth Factor Beta 1 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transforming Growth Factor Beta 1 Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Transforming Growth Factor Beta 1 Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Transforming Growth Factor Beta 1 Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Pirfenidone
Figure 10. Product Picture of Galunisertib
Figure 11. Product Picture of Others
Figure 12. Global Transforming Growth Factor Beta 1 Sales Market Share by Type in 2021
Figure 13. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2017-2022)
Figure 14. Transforming Growth Factor Beta 1 Consumed in IPF
Figure 15. Global Transforming Growth Factor Beta 1 Market: IPF (2017-2022) & (K Units)
Figure 16. Transforming Growth Factor Beta 1 Consumed in Cancer
Figure 17. Global Transforming Growth Factor Beta 1 Market: Cancer (2017-2022) & (K Units)
Figure 18. Transforming Growth Factor Beta 1 Consumed in Others
Figure 19. Global Transforming Growth Factor Beta 1 Market: Others (2017-2022) & (K Units)
Figure 20. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)
Figure 21. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application in 2021
Figure 22. Transforming Growth Factor Beta 1 Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Transforming Growth Factor Beta 1 Revenue Market Share by Company in 2021
Figure 24. Global Transforming Growth Factor Beta 1 Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Transforming Growth Factor Beta 1 Revenue Market Share by Geographic Region in 2021
Figure 26. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2017-2022)
Figure 27. Global Transforming Growth Factor Beta 1 Revenue Market Share by Country/Region in 2021
Figure 28. Americas Transforming Growth Factor Beta 1 Sales 2017-2022 (K Units)
Figure 29. Americas Transforming Growth Factor Beta 1 Revenue 2017-2022 ($ Millions)
Figure 30. APAC Transforming Growth Factor Beta 1 Sales 2017-2022 (K Units)
Figure 31. APAC Transforming Growth Factor Beta 1 Revenue 2017-2022 ($ Millions)
Figure 32. Europe Transforming Growth Factor Beta 1 Sales 2017-2022 (K Units)
Figure 33. Europe Transforming Growth Factor Beta 1 Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Transforming Growth Factor Beta 1 Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Transforming Growth Factor Beta 1 Revenue 2017-2022 ($ Millions)
Figure 36. Americas Transforming Growth Factor Beta 1 Sales Market Share by Country in 2021
Figure 37. Americas Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2021
Figure 38. United States Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Transforming Growth Factor Beta 1 Sales Market Share by Region in 2021
Figure 43. APAC Transforming Growth Factor Beta 1 Revenue Market Share by Regions in 2021
Figure 44. China Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country in 2021
Figure 51. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2021
Figure 52. Germany Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2021
Figure 59. Egypt Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Transforming Growth Factor Beta 1 in 2021
Figure 65. Manufacturing Process Analysis of Transforming Growth Factor Beta 1
Figure 66. Industry Chain Structure of Transforming Growth Factor Beta 1
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...